PNC Financial Services Group
ELDN icon

PNC Financial Services Group’s Eledon Pharmaceuticals ELDN Stock Holding History

PNC Financial Services Group’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.34K Buy
1,102
+165
+18% +$600 ﹤0.01% 4443
2026
Q1 		$2.89K Buy
937
+932
+18,640% +$2.19K ﹤0.01% 4471
2025
Q4 		$8 Sell
5
-4
-44% -$10 ﹤0.01% 5142
2025
Q3 		$23 Buy
+9
New +$26 ﹤0.01% 5056

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

PNC Financial Services Group's ELDN Position: Q2 2026 in Review

PNC Financial Services Group increased its Eledon Pharmaceuticals (ELDN) stake by 18% in Q2 2026, buying an estimated $600 and bringing the position to 1,102 shares worth $4.34K. The position accounts for ﹤0.01% of the portfolio, ranked #4443.

PNC Financial Services Group first reported a position in ELDN in Q3 2025 and has held it in 4 quarters since. 161 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • PNC Financial Services Group held 1,102 shares of Eledon Pharmaceuticals worth $4.34K as of Q2 2026.
  • PNC Financial Services Group bought 165 Eledon Pharmaceuticals shares in Q2 2026, an estimated $600.
  • Eledon Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4443 holding.
  • PNC Financial Services Group first reported a position in Eledon Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 161 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.